Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yu B Ubshaeva"'
Publikováno v:
Терапевтический архив, Vol 87, Iss 12, Pp 36-40 (2015)
Aim. To study the promoter regions of the matrix metalloproteinase (MMP)2, MMP3, and MMP9 genes to assess their associations with the risk of rheumatoid arthritis (RA) and with the types of its clinical course in women. Subjects and methods. 162 fema
Externí odkaz:
https://doaj.org/article/bb0ca490954142a485410009a07f2c85
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 3, Pp 240-245 (2013)
Objective: to study the distribution of the genotypes of the vascular endothelial growth factor (VEGF) gene and their combinations with those of other cytokines among patients with rheumatoid arthritis (RA) and healthy individuals. Subjects and metho
Externí odkaz:
https://doaj.org/article/2bf527209ed14379ba2d483b62865d99
Autor:
A. A. Akimova, N. E. Banshchikova, A. E. Sizikov, A. A. Mullagaliev, E. A. Letyagina, N. A. Ilina, Yu. D. Kurochkina, Yu. B. Ubshaeva, V. O. Omelchenko, O. A. Chumasova, N. S. Shkaruba, M. A. Korolev
Publikováno v:
Rheumatology Science and Practice. 61:25-33
The COVID-19 pandemic has significantly changed the understanding of the safety profile of therapies for immunoinflammatory rheumatic diseases (IRDs). This is primarily due to the negative impact of a number of basic anti-inflammatory drugs (DMARDs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5aa1cb68029af788f819a3966d7b3dc3
https://doi.org/10.47360/1995-4484-2023-25-33
https://doi.org/10.47360/1995-4484-2023-25-33
Publikováno v:
Rheumatology Science and Practice. 60:460-464
Aim – to investigate relationship of trabecular bone score (TBS) with activity and structural progression of ankylosing spondylitis (AS) in males younger than 50 years old without osteoporosis.Materials and methods. 26 male AS patients took part in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a3fd59c0712abf345875f071574ee93
https://doi.org/10.47360/1995-4484-2022-460-464
https://doi.org/10.47360/1995-4484-2022-460-464
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 6, Pp 663-672 (2021)
Wide usage of biologic disease-modifying anti-rheumatic drugs (DMARDs) biosimilars in clinical practice has greatly increased the availability of biologic therapy for rheumatic patients. Nevertheless, not only economic expediency but efficacy and saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::433dbd3e8742bdaf14a695c12e55c018
https://rsp.mediar-press.net/rsp/article/view/2965
https://rsp.mediar-press.net/rsp/article/view/2965
Autor:
V F Prokofiev, Yu B Ubshaeva, Maxim Aleksandrovich Korolev, A V Shevchenko, Vladimir I. Konenkov
Publikováno v:
Терапевтический архив, Vol 87, Iss 12, Pp 36-40 (2015)
To study the promoter regions of the matrix metalloproteinase (MMP)2, MMP3, and MMP9 genes to assess their associations with the risk of rheumatoid arthritis (RA) and with the types of its clinical course in women.162 female patients with RA and 329
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf58ad5ef4e97a6574e48a8be0b17a37
https://ter-arkhiv.ru/0040-3660/article/view/31869
https://ter-arkhiv.ru/0040-3660/article/view/31869
Autor:
Maxim Aleksandrovich Korolev, A V Shevchenko, Vladimir I. Konenkov, Viktor Fedorovich Prokofyev, Yu B Ubshaeva
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 3, Pp 240-245 (2013)
Objective: to study the distribution of the genotypes of the vascular endothelial growth factor (VEGF) gene and their combinations with those of other cytokines among patients with rheumatoid arthritis (RA) and healthy individuals. Subjects and metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82f19ef25f99ccf056ce3e2745ec7f01
https://rsp.mediar-press.net/rsp/article/view/1311
https://rsp.mediar-press.net/rsp/article/view/1311
Autor:
A. V. Fedorova, N. E. Banshchikova, A. E. Sizikov, A. A. Mullagaliev, E. A. Letyagina, A. A. Akimova, N. A. Ilyina, Yu. D. Kurochkina, Yu. B. Ubshaeva, V. O. Omelchenko, O. A. Chumasova, N. S. Shkaruba, M. A. Korolev
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 25-31 (2024)
In the context of the new coronavirus infection (NCI) COVID-19 pandemic, the rheumatological community is facing new challenges in the treatment of immune-inflammatory rheumatic diseases (IIRDs). It has been shown that rheumatological patients have a
Externí odkaz:
https://doaj.org/article/7e2094d9d4c04da1883375affe7e3353